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Sher and Coffman, 1992) or during chronic diseases
in humans (Romagnani, 1994). This explains why such
populations were originally difficult to obtain from hu-
man systems, since such attempts involved stimulation
of peripheral blood T cells from healthy individuals with
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mitogens (Romagnani, 1994). Indeed, human Th1- andThe discovery that subsets of CD41 T cells could be dis-
Th2-type populations have now been isolated from pe-tinguished according to their ability to produce discrete
ripheral blood, draining lymph nodes and affected tis-patterns of cytokines offered a logical explanation for
sues during chronic infectious diseases and allergy (re-early observations that differential immune responses
viewed in Romagnani, 1994).can be elicited in response to antigen. Early events in an
Although IL-2 production has often been associatedimmune response stimulate the production of cytokines
with a Th1 phenotype, the production of this cytokinethat direct the subsequent development of these T
cannot be classified as a hallmark of Th1 cells, sincehelper (Th) subsets with these discrete patterns of cyto-
naive CD41 T cells as well as Th0 cells (described below)kine production (Mosmann et al., 1986). The develop-
also produce IL-2 in response to antigenic stimulationment of these distinct Th subsets is strongly dictated
(Sher and Coffman, 1992; Romagnani, 1994; Abbas etby the type of antigen/microorganism invading a host,
al., 1996). Helper T cells and clones that produce bothas well as the genetic background of the host, and it is
Th1- and Th2-type cytokines (termed Th0) have beenlikely that the dose and route of immunization of antigen
described in human and mouse systems (Sher and Coff-may also be determining factors (Seder and Paul, 1994;
man, 1992; Romagnani, 1994; Kelso, 1995; Abbas et al.,Abbas et al., 1996; Constant and Bottomly, 1997).
1996). Whether Th0 cells are precursors for Th1 and
Th2 cells or represent a separate, stably differentiated
Heterogeneity of T Cell Populations population remains unclear (Kamogawa et al., 1993). It
Th1 cells, by their production of interferon-g (IFNg) and is possible that Th0 cells are involved in eliminating
lymphotoxin, are responsible for directing cell-mediated many pathogens, where a balance of both regulated
immune responses leading to the eradication of intracel- cell-mediated immunity and an appropriate humoral re-
lular pathogens (Mosmann et al., 1986; Sher and Coff- sponse will eradicate an invading pathogen with mini-
man, 1992), but they may also cause immunopathology mum immunopathology. However, chronic conditions
and organ-specific autoimmune disease if dysregulated may result in polarized Th1- and Th2-type responses,
(O'Garra and Murphy, 1993; Powrie and Coffman, 1993; which, by the counter-regulatory effects of thecytokines
made by the reciprocal subsets, may not only be mutu-Scott et al., 1994; Liblau et al., 1995). Because cytokines
ally exclusive but in addition pathogenic (Alwan et al.,produced by Th2 cells, such as interleukin (IL)-4 and
1994). To what numerical extent Th1 and Th2 cells domi-IL-5, can activate mast cells and eosinophils and in
nate such in vivo responses is as yet not clear, but theiraddition can result in elevated levels of IgE, they have
ability to influence chronic disease or pathology by theirbeen strongly implicated in atopy and allergic inflamma-
production of high levels of regulatory cytokines is nottion (Romagnani, 1994). The production of B cell growth
in doubt.and differentiation factors by Th2 cells may in part
Th1 cells, important for cell-mediated immunity byexplain why certain immune responses are predomi-
their production of IFNg and lymphotoxin, have beennantly humoral, whereas delayed-type hypersensitivity
implicated in the immunopathology of certain organ-responses, seen in other circumstances, are readily at-
specific autoimmune diseases (Powrie and Coffman,tributable to Th1 cells (Mosmann and Coffman, 1989).
1993; Scott et al., 1994; Liblau et al., 1995). The hypoth-The ability of cytokines to stimulate different effector
esis that protection from autoimmune diseases, suchmechanisms and thus differential immune responses is
as experimental allergic encephalomyelitis and insulin-also reinforced by the production of cytokines by each
dependent diabetes mellitus, could be achieved by asubset, which cross-regulate each other's function as
ªTh1 to Th2 switchº (Fowell and Mason, 1993; O'Garrawell as development.
and Murphy, 1993; Powrie and Coffman, 1993; Scott et
For example, IFNg produced by Th1 cells inhibits the
al., 1994; Liblau et al., 1995) and that administration of
development of Th2 cells (Fitch et al., 1993) as well as
soluble antigen without adjuvant (De Wit et al., 1992;
humoral responses, whereas the production of IL-4 and Burstein and Abbas, 1993) or oral adminstration of solu-
IL-10 by Th2 cells inhibits Th1 development and activa- ble antigen (Weiner, 1997) led to unresponsiveness has
tion as well as macrophage activation and bactericidal triggered not only many studies for treatment of autoim-
activity (Sher and Coffman, 1992; Moore et al., 1993). mune diseases in mouse models but in addition has
One feature, which should be considered with respect influenced the design of therapeutic strategies (Weiner,
to polarized Th1 and Th2 responses, is that they repre- 1997). Many studies now suggest that alternative regula-
sent endpoints of chronic immunization or chronic dis- tory populations exist, which are somehow associated
ease. Th1 and Th2 clones were generally isolated from with, but distinct from, Th2 cells (Bridoux et al., 1997;
hyperimmunized mice (Mosmann and Coffman, 1989; Lafaille et al., 1997; Pakalaet al., 1997). Regulatory CD41
T cell subsets have been described that can inhibit cell-
mediated immune responses and/or inflammatory pa-* To whom correspondence should be addressed (e-mail: aog@
dnax.org). thologies (Powrie and Mason, 1990; Fowell and Mason,
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Figure 1. Regulation of Th Responses
Naive CD41 T cells can develop into Th1 cells responsible for cell-mediated immunity in response to IL-12 with the participation in BALB/c
mice of other cofactors, such as IL-1a and IGIF. Th1 development is dependent on IFNg, and maintenance of phenotype depends on stimulation
in the presence of IL-12 and IGIF. Development of Th1 responses can be antagonized directly by IL-4 and indirectly by IL-10, which inhibits
the production of inflammatory mediators, such as IL-12 and IGIF, from macrophages stimulated by the innate immune response. Th2 cells
dependent on IL-4 to differentiate have been implicated in allergic and atopic manifestations, and in addition through their production of IL-4
and IL-10 they have been suggested to play a role in tolerance; specifically, it has been suggested that a Th1 to Th2 switch may prevent the
development of organ-specific autoimmune pathologies. In the last year it has become clear that distinct subsets of regulatory T cells are
responsible for regulating both Th1 and Th2 responses and preventing the development of immune pathologies. A common feature of many
of these regulatory T cells is that their function is at least in part due to the action of TGFb; this would be in keeping with the ability of TGFb
to inhibit both Th1 and Th2 development.
1993; Chen et al., 1994; Powrie et al., 1996; Groux et antigen receptors (Tg-TCR) of known specificities, it has
become clear that Th1 and Th2 subsets develop fromal., 1997; Bridoux et al., 1997; Weiner, 1997). The mainte-
nance of self tolerance, at least in part, appears to de- the same T cell precursor (Hsieh et al., 1992; Rocken et
al., 1992; Kamogawa et al., 1993; Seder and Paul, 1994),pend on active T cell regulation. Although Th2-derived
cytokines can sometimes play a role in this process, it which is a mature, naive CD41 T lymphocyte producing
mainly IL-2 upon antigen-specific stimulation. The mostis now clear that distinct subsets of regulatory cells
exist, which not only inhibit inflammatory responses that clearly defined factors determining Th1 and Th2 differ-
entiation from this precursor are cytokines present atlead to autoimmunity (Powrie and Mason, 1990; Powrie
et al., 1996; Bridoux et al., 1997; Groux et al., 1997; the initiation of the immune response at the stage of
ligation of the TCR (Seder and Paul, 1994; Abbas et al.,Weiner, 1997) but also inhibit inflammatory pathologies
mediated by Th2-type cells (Bridoux et al., 1997; Lafaille 1996). For example, bacterial stimuli activate macro-
phages and subsequently natural killer (NK) cells of theet al., 1997; Pakala et al.,1997). Much of this suppression
has been shown to be at least in part attributable to innate immune response to produce IL-12 and IFNg,
respectively (Hsieh et al., 1993; Trinchieri, 1995), whichtransforming growth factor b (TGFb) (Powrie et al., 1996;
Bridoux et al., 1997; Weiner, 1997), and this is not sur- then drive the development of Th1 cells from naive anti-
gen-specific T cells. This type of innate immune re-prising in view of the ability of TGFb to inhibit both
Th1 and Th2 development (Figure 1) (Swain et al., 1991; sponse and its accompanying antigen-specific T cell
response are appropriate for the eradication of microbialSchmitt et al., 1994).
pathogens (Sher and Coffman, 1992; Trinchieri, 1995).
Conversely, production of IL-4 early in an immune re-Development of T Helper Cell Subsets
Two main types of systems have helped to determine sponse directs the development of a Th2 or allergic/
humoral immune response from naive precursors; how-the factors involved in directing Th1 and Th2 phenotype
development. Using T cells stimulated with polyclonal ever, the cell sources producing this early burst of IL-4,
and the mechanism for its induction are still not clearlyactivators or T cells from mice expressing transgenic
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understood (Seder and Paul, 1994). This area of immune which counteracts the inhibitory effects of IL-4 (Rogge
et al., 1997; Szabo et al., 1997). Thus, BALB/c mice,regulation has been the subject of intense research for
the last few years. which produce a substantial amount of IL-4 (Guler et
al., 1996), may inhibit the IL-12Rb2 expression, imposing
the reported requirement for IFNg in Th1 development
Cytokine-Induced Th1 Development and (Szabo et al., 1997).
Maintenance of Th1 Phenotype Recent data have suggested a role for cofactors in
IL-12 is a dominant factor in directing the development induction of both development of Th1 cells and IFNg
of Th1 cells producing high levels of IFNg (Hsieh et al., production from committed Th1 cells. IL-1-a acts as a
1993; Manetti et al., 1993; Trinchieri, 1995). IL-12 is a 75 cofactor in IL-12±induced Th1 development in BALB/c
kDa heterodimer (Trinchieri, 1995) shown to be pro- but not C57BL/6 mice; however, IL-1-a responsiveness
duced by macrophages upon their encounter with many is lost by committed Th1 cells and clones (Robinson et
microbial products, including lipopolysaccharide and al., 1997), in agreement with previous reports of loss of
components of viruses, intracellular bacteria such as IL-1-a binding by Th1 clones (Lichtman et al., 1988).
Listeria monocytogenes and mycobacteria, and proto- Interferon-g±inducing factor (IGIF) was discovered in
zoa such as Toxoplasma via as yet undefined mecha- studies of IFNg production in a Proprionobacterium
nisms (Gazzinelli et al., 1993; Hsieh et al., 1993; Trin- acnes±induced model of toxic shock (Okamura et al.,
chieri, 1995). Interestingly, some organisms, such as 1995). This cytokine was subsequently characterized as
measles, have the ability todown-regulate IL-12 produc- active in promoting proliferation and IFNg production
tion by monocytes and thus evade destruction by the by Th1 clones and lines, and NK cells in both mouse
cell-mediated limb of the immune response (Karp et al., and human (Okamura et al., 1995; Ushio et al., 1996).
1996). Dendritic cells are professional antigen-pre- Structural analysis and fold recognition (Bazan et al.,
senting cells (APC) specialized in antigen capture, mi- 1996) suggest that IGIF belongs to the IL-1 family. IGIF,
gration to secondary lymphoid organs, and T cell prim- unlike IL-12, does not drive Th1 development, but like
ing (Steinman, 1991), which can under certain conditions IL-1-a it potentiates IL-12±induced Th1 development in
also produce IL-12 (Macatonia et al., 1995; Scheicher the BALB/c but not C57BL/6 mouse strain (Robinson et
et al., 1995). Recent studies have demonstrated that al., 1997). IGIF synergizes with IL-12 in inducing IFNg
ligation of CD40 by the CD40 ligand (Cella et al., 1996; production from differentiating and committed Th1 cells
Koch et al., 1996) and/or class II (Koch et al., 1996) on from both BALB/c and C57BL/6 mice (Robinson et al.,
dendritic cells can induce the production of high levels 1997), as well as inducing IFNg production by NK cells
of IL-12. Both IL-4 and IL-10 have the ability to inhibit in both mouse and human as well as T cell clones (Oka-
both dendritic cell (Macatonia et al., 1995; Koch et al., mura et al.,1995; Ushioet al., 1996), suggesting that both
1996) and macrophage-derived (D'Andrea et al., 1993; IL-12 and IGIF are required for significant expression of
Hsieh et al., 1993; Murphy et al., 1994) IL-12 production the Th1 phenotype.
and thus inhibit the development of Th1 cells. Unlike IL-12, IGIF does not activate Stat4 in Th1 cells
IL-12 directs Th1 development from antigen-stimu- (Robinson et al., 1997). IL-1-a signaling is via a receptor-
lated naive CD41 T cells (Hsieh et al., 1993; Manetti et associated kinase termed IRAK, which activates a cas-
al., 1993; Trinchieri, 1995) and activates Stat3 and Stat4 cade of kinases leading to activation of NF-kB (Cao et
in Th1 cells (Jacobson et al., 1995; Szabo et al., 1995). al., 1996). IGIF also signals through the IRAK pathway
Gene deletion of IL-12 (Magram et al., 1996) or Stat4 to induce nuclear translocation of the p65/p50 NF-kB
(Kaplan et al., 1996a; Thierfelder et al., 1996) shows that complex in Th1 cells (Robinson et al., 1997). In contrast
IL-12 signaling through this pathway is required in vivo, IL-1-a, which showed no effect on Th1 cells, activated
since both result in markedly reduced Th1 responses. NF-kB and induced proliferation of Th2 cells, which did
Responsiveness to IL-12 is impaired in BALB/c mice not respond to IGIF (Robinson et al., 1997). Th1 and
(Guler et al., 1996), which results in the nonhealing Th2 Th2 cells thus differ in responsiveness and receptor
response to Leishmania major infection (Locksley and expression for IL-1 family molecules, and thus IGIF and
Scott, 1991). Among CD41 T cells functional receptors IL-1-a, by signaling through NF-kB, may differentially
for IL-12 appear to be restricted to recently activated, amplify Th1 and Th2 effector responses, respectively.
uncommitted cells and to Th1 cells, and they are lost
during differentiation of Th2 cells (Szabo et al., 1995).
Th1 development is also dependent on IFNg (Belosevic Cytokine-Induced Th2 Development
The development of Th2 cells has been attributed to theet al., 1989; Hsieh et al., 1993), although the requirement
for this factor was confusing and controversial for a exposure of naive CD41 T cells to IL-4 at the initiation
of an immune response (Le Gros et al., 1990; Swain etnumber of years. The effects of IFNg on Th1 develop-
ment may be mediated via action on the macrophage al., 1990; Seder and Paul, 1994). The effects of IL-4
in inducing Th2 development are dominant over Th1to up-regulate IL-12 production (Trinchieri, 1995) or by
direct effects on the T cell. The molecular basis of IL- polarizing cytokines (Hsieh et al., 1993; Seder and Paul,
1994), so that if IL-4 levels reach a certain threshold at12 unresponsiveness of Th2 cells has recently been de-
lineated in both mouse and human systems (Rogge et the beginning of an immune response, Th2 cells will
differentiate, leading to increasing levels of IL-4 progres-al., 1997; Szabo et al., 1997). This is at least in part
due to down-regulation of the IL-12Rb2 by IL-4 and sively. This may explain why chronic stimulation, partic-
ularly in the absence of inflammatory signals deliveredfurthermore the up-regulation of the IL-12Rb2 by IFNg,
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during the innate immune response, as well as the mag- studies ruled out the contributions of TL to the NK11 T
cell repertoire by performing an analysis of CD1-defi-nitude of an immune response, may drive Th2 responses
cient mice that additionally do not express TL in the(Abbas et al., 1996). It was originally thought that IL-4
thymus. In accordance with the earlier study (Smiley etwas only produced by differentiated T helper cells, and
al., 1997), CD1 deficiency led to a marked reduction ofyet this factor is required early in an immune response
NK11 T cell numbers in the thymus, spleen, and liver,for the development of Th2 cells (Abbas et al., 1996).
which was accompanied by a dramatic decrease in earlyThere are now several candidates for IL-4 production
IL-4 production induced by anti-CD3 both in vitro andearly in an immune response, which may be responsible
in vivo (Chen et al., 1997; Mendiratta et al., 1997). Infor Th2 differentiation; these include major histocompat-
addition, comparable levels of IgE were also inducedibility complex (MHC) class II±restricted CD41 T cells
after injection of goat anti-mouse IgD serum in both(memory and possibly naive) (Bradley et al, 1991; Con-
these CD1-deficient mice and control littermates (Chenstant et al., 1995; Hosken et al., 1995), the NK11 subset
et al., 1997, Mendiratta et al., 1997). These studies wereof CD41 and double negative (DN) T cells (reviewed
all in contrast to studies in the b2M-deficient mice (Yo-in Bendelac et al., 1997), LACK-specific CD41 T cells
shimoto et al., 1995). Such differences in findings be-expressing Vb4, Vb8 TCR (Julia et al., 1996), and non±T
tween the b2M-deficient versus CD1-deficient micecell sources, such as mast cells, basophils, and eosino-
could result from different genetic backgrounds, a com-phils (reviewed in Paul et al., 1993).
pensation for IL-4-dependent IgE switching by an alter-Many researchers have suggested a critical role for
native stimulus (Morawetz et al., 1996), or because b2M-NK11 T cells in Th2 differentiation as a result of their
deficient mice not only lack CD1 expression and NK11ability to produce large amounts of IL-4 rapidly upon
T cells but are also deficient in other immunologicalactivation both in vitro and in vivo with anti-CD3 (re-
compartments (reviewed in Bendelac et al., 1997). How-viewed in Bendelac et al., 1997) and of their role in the
ever, in line with the findings previously reported in thedevelopment of IgE production in response topolyclonal
b2M-deficient mice, it was also demonstrated that nor-activation with anti-IgD in vivo (Yoshimoto et al., 1995).
mal levels of IL-4 were generated in a recall responseThese T cells (CD41; and CD42, CD82 [DN]) are rather
to the particulate antigen keyhole limpet hemocyanin inunusual in that they express many NK cell markers, as
adjuvant (Chen et al., 1997). In total, these studies con-well as markers typical of activated/memory cells, have
firm that CD1 is the selecting antigen for NK11 T cells
a restricted TCR Va and Vb usage, and are restricted
and that these cells account for the early burst of IL-4
by nonclassical MHC class Imolecules (reviewed in Ben-
obtained after anti-CD3 activation. However, IL-4 pro-
delac et al., 1997). In the mouse, there are two molecules
duction by NK1.1 cells is not needed for the develop-
whose expression is dependent on b2M-microglobulin
ment of Th2 responses to specific antigens. These data
but not the TAP peptide transporter that are candidate
are in agreement with recent studies with mice rendered
ligands for NK11 T cells: CD1 and the thymus leukemia deficient of NK11 T cells by depletion with anti-NK1.1
(TL) antigen, which belong to a large group of nonclassi- antibodies (von der Weid et al., 1996). Thus, the precise
cal class Ib molecules and are proposed to function as role of NK11 T cells in the development of Th2 responses
ligands for NK11 T cells (reviewed in Bendelac et al., remains unclear.
1997). CD1 expression and assembly are b2M-depen- The requirement for IL-4 in mediating both Th2 differ-
dent and, although not dependent on invariant chain entiation and susceptibility to the parasite L. major has
and DM, CD1 traffics to the MHC class II compartment directed much interest toward the early IL-4 produced
and does not require functional TAP-1 and TAP-2 pep- in vivo during infection with this organism (Sadick et al.,
tide transporters for surface expression (reviewed in 1990; Locksley and Scott, 1991). It has been recently
Bendelac et al., 1997). A number of recent studies using demonstrated that the early burst of IL-4 peaking in
b2M-deficient mice have failed to support a role for lymph nodes of susceptible BALB/c mice after L. major
these NK11 cells in the development of Th2 responses infection occurs within CD41 T cells that express Vb4
to a variety of parasitic microbes and protein antigens Va8 T cell receptors (Julia et al., 1996; Launois et al.,
(reviewed in Bendelac et al., 1997). However, b2M-defi- 1997). A previously identified antigen,Leishmania homo-
cient mice not only lack CD1 expression and NK11 T log of receptors for activated C kinase (LACK) was found
cells but are also deficient in the surface expression of to be the focus of this initial response (Julia et al., 1996).
most classical and nonclassical MHC class I molecules, A role for LACK-specific T cells in the development of
have a substantial reduction in their numbers of CD81 a dominant Th2 response to L. major infection in BALB/c
T lymphocytes, and have other additional defects, which mice was demonstrated when mice were rendered unre-
may influence immune responses (reviewed in Bendelac sponsive to LACK (Julia et al., 1996). Due to expression
et al., 1997). of LACK as a transgene, BALB/c mice were made toler-
The precise role of NK11 T cells in the differentiation of ant to this antigen and developed a reduced Th2 re-
Th2 responses hasrecently been addressed by infection sponse and a protective Th1 response when infected
and immunization studies in CD1-deficient mice. Mice with L. major. The mechanism whereby LACK induces
deficient in CD1 were found to lack the NK11 subset but a Th2 response in BALB/c mice is still unclear. That
could nevertheless mount a prototypical Th2 response early IL-4 induced by LACK is so rapid is reminiscent
(Smiley et al., 1997). After immunization with antibody of a ªmemoryº response (Bradley et al., 1991) and may
to immunoglobulin D (IgD), CD1-deficient mice pro- result from previous activation of T cells by cross-reac-
duced IgE. Thus, although dependent on CD1 for their tive antigens. BALB/c mice depleted of Vb4 T cells by
development, IL-4±secreting NK-like T cells are not re- neonatal infection with a specific mouse mammary tu-
mor virus, MMTV(SIM), were shown to be resistant toquired for Th2 responses (Smiley et al., 1997). Further
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L. major infection and did not produce this early burst development of effector T helper cells takes several
days (Lederer et al., 1996). Therefore, while it is clearof IL-4. The experiments were controlled for the possible
adjuvant effect of the virus, since mice deleted for Vb6 that Stats are essential early signal transducers in Th
subset differentiation, they are unlikely to determine Thwith MMTV(SW) remained susceptible to the parasite.
Recombinant LACK antigen from L. major, shown pre- phenotype development directly. Alternatively, it is pos-
sible that Stat activation together with TCR signalingviously to activate Vb4 Va8 CD41 T cells (Julia et al.,
1996), was demonstrated to cause IL-4 mRNA produc- results in a cascade of changes of gene expression that
ultimately leads to the development of effector pheno-tion with similar kinetics and at comparable levels, as
did the intact parasites. IL-4 production from memory types of Th1 and Th2 cells. Two transcription factors,
c-Maf (Ho et al., 1996) and NF-IL-6 (Davydov et al., 1995),T cells could affect the subsequent development of Th2
cells from naive precursors, as previously shown (Brad- have recently been shown to be expressed in Th2 cells
and to activate the IL-4 gene promoter. However, theley et al., 1991; Macatonia et al., 1995). However, it is also
possible that this antigen induces a rapid IL-4 response selective expression of these two transcription factors
was observed in fully differentiated Th2 cells, and theirfrom naive T cells, as has been suggested in other sys-
tems (Rocken et al., 1992; Kamogawa et al., 1993; Con- role in differentiation of Th2 cells from naive precur-
sors is less clear. More recently, a transcription factorstant et al., 1995; Hosken et al., 1995; Rincon et al.,
1997). Interestingly, injection of recombinant LACK into GATA-3 was found to be selectively expressed in differ-
entiating and effector Th2 but not Th1 cells (Zheng andresistant C57Bl/6 mice results in small, but detectable
amounts of IFNg mRNA at 16 hr, indicating that recogni- Flavell, 1997). Interestingly, GATA-3 was shown to be
required for the transcription of all Th2 genes, and thetion of this antigen is not invariably associated with IL-4
production. loss of Th2 cytokine gene expression in Th1 cells ap-
peared to be at least in part a consequence of the down-It was suggested that the genetic susceptibility to L.
major requires not only a polymorphism in Th subset regulation of GATA-3. To date, six transcription factors
(Stat-6, c-Maf, NF-IL-6, NF-AT, AP-1, and GATA-3) havedevelopment (Guler et al., 1996) but also the proper
thymic environment for the selection of sufficient num- been implicated in Th2 cell differentiation (Davydov et
al., 1995; Rooney et al., 1995; Ho et al., 1996; Kaplan etbers of Vb4 Va8, CD41 LACK-specific T cells to direct
Th2 development of subsequently activated CD41 T al., 1996; Rincon and Flavell, 1997; Zheng and Flavell,
1997). However, the precise mechanisms of how thesecells (Launois et al., 1997). The complexity of the geno-
types required to mediate susceptibility or resistance factors interact and lead to Th2 differentiation remain
to be clarifed.to this organism appears to be greater than originally
anticipated. Using a novel serial backcross approach
to map loci linked (and/or associated) with Leishmania
Other Factors Affecting Th Subset Developmentresistance, it has been elegantly shown that loci on six
Although key cytokines, including IL-12 and IFNg, ordistinct chromosomal regions can influence the immune
IL-4, undoubtedly play a central role in governing theresponse to this pathogen (Beebe et al., 1997), reinforc-
differentiation of Th1 and Th2 effector cells from naiveing the multigenic nature of resistance to this disease.
precursors (Abbas et al., 1996), models have been pro-That non±T cells may also play a role in the initiation
posed whereby the strength of interaction mediatedof Th2 responses against some pathogens in specific
through the TCR and MHC/peptide complex or the dosetissues is clear, since mast cells, basophils, and eosino-
of antigen might directly affect lineage commitment ofphils can produce cytokines such as IL-4 (reviewed in
CD41 T cells (Constant et al., 1995; Hosken et al., 1995;Paul et al., 1993).
Constant and Bottomly, 1997). The mechanisms under-IL-4 ligand binding to its receptor ultimately results in
lying the effects of antigen dose on Th subset develop-signaling through activation of Stat-6 and in addition
ment are as yet unclear. However, it is likely that somethrough phosphorylation of the insulin receptor sub-
of the effects are mediated by altering the balance ofstrate 2 (Hou et al., 1994; Ryan et al., 1996). Gene dele-
endogenous levels of IL-4 versus IL-12 or IFNg produc-tion of the IL-4 gene significantly reduces Th2-type re-
tion by T cells or APC, thus tilting the developmentsponses (Kuhn et al., 1991; Kopf, et al., 1993). Although
toward Th2 or Th1 responses, respectively. This is sup-targeted disruption of the Stat-6 gene (Kaplan et al.,
ported by in vitro studies in which low-dose or very high-1996b; Shimoda et al., 1996; Takeda et al., 1996) results
dose antigen-driven Th2 development is abrogated byin deficient Th2 responses, the mechanism by which
addition of neutralizing antibodies directed against IL-4Stat-6 induces IL-4 production and Th2 development
(Hosken et al., 1995). In vivo, the nature of the antigenremains unclear. The requirement for Stat-6 to maintain
as well as the dose may determine whether macro-IL-4 production is also supported by a recent study in
phages or dendritic cells are triggered to produce IL-which it was shown that IL-4R±mediated tyrosine phos-
12 and thus drive a Th1-type response (Hsieh et al.,phorylation is impaired in Th1 cells (Kubo et al., 1997).
1993; Macatonia et al., 1995; Trinchieri, 1995). OtherA consensus Stat-6±binding site is present in the IL-4
factors suggested to influence T cell subset develop-promoter, and a multimer of this site is capable of stimu-
ment are membrane-bound costimulators, such as B7-1lating transcription of a reporter gene in response to
and B7-2, which are signals provided by APC that to-IL-4 (Lederer et al., 1996). This suggests that Stat-6 may
gether with antigen have been shown to enhance spe-activate IL-4 transcription in response to IL-4 itself and
cific T cell responses via their interaction with CD28in this way play a role in IL-4±driven Th2 development.
(Kuchroo et al., 1995). It has been shown in some sys-However, whereas activation of Stat proteins is a tran-
sient event that occurs rapidly upon stimulation, the tems that such costimulators may differentially regulate
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Figure 2. Th1 but Not Th2 Cells Remain Re-
sponsive to Both IL-12 and IGIF
Committed Th2 cells lose their ability to re-
spond biologically both to IL-12 andIGIF, per-
haps in part explaining why they cannot make
Th1-type cytokines such as IFNg upon stimu-
lation. Loss of IL-12 responsiveness and
Stat-4 activation results from preferential loss
of the IL-12R-b2. IL-4 can down-regulate IL-
12R-b expression, whereas IFNg up-regu-
lates expression. The inability of IGIF to signal
through IRAK to induce nuclear translocation
of p65/p50 NF-kB in Th2 cells, in contrast to
Th1 cells, suggests a possible loss of the IGIF
receptor by Th2 cells, which in contrast main-
tain expression of the type 1 IL-1R.
Th1 and Th2 development, although the mechanism for It is very likely that the development of T helper sub-
sets may depend on the nature of an invading pathogenthese phenomena is unclear (Kuchroo et al., 1995). Fur-
thermore, Th cells that do not express the CD4 corecep- or the type of antigen, the route and dose of entry of
the antigen/microorganism, as well as the genetic back-tor are deficient in their capacity to differentiate into Th2
cells in response to antigen in vivo or in vitro (Brown et ground of the host. However, the most clearly defined
factors determining Th subset differentiation from naiveal., 1997; Fowellet al., 1997). This deficiency was evident
using both CD4-negative cells from CD4-gene disrupted CD41 T cell precursors are cytokines present at the
initiation of the immune response at the stage of ligationmice and the DN T cells that developed in MHC class
II±restricted TCR transgenic mice. The defect in the of the TCR. IL-12 and IFNg are important factors induc-
ing the development of Th1 cells, and high levels ofability to produce IL-4 was observed in response to
disparate challenges, including intestinal helminths and IFNg production from committed Th1 cells result from
activation in the presence of IL-12 and IGIF. Th1 cellsintracellular parasites. Furthermore, the lack of a Th2
response was also evident when CD41 T cells were are important effectors involved in the eradication of
infectious pathogens, but if inappropriately activatedprimed by APCs that expressed mutated MHC class II
molecules that were unable to bind CD4. It would appear they can cause immunopathology. In contrast, Th2 cells,
whose development is induced by IL-4, have been impli-that the coreceptor, perhaps by modulating the strength
of the signal delivered to the T cell, may influence Th cated in humoral immune responses and the eradication
of helminths, but they may also result in inflammatorysubset development. Other factors that have been shown
to initiate or enhance Th2 development are IL-6 (Rincon damage during allergic manifestations and atopy. Th2
cells have been suggested toplay a role in theprotectionet al., 1997) and monocyte chemoattractant protein 1
(Karpus et al., 1997). However, since development of of tissues and organs from autoimmune attack as a
result of their production of antiinflammatory cytokines,these Th2 responses is neutralized by addition of anti-
IL-4 antibodies, it is likely that they may drive Th2 devel- such as IL-4 and IL-10. Current thinking is that such
regulation is achieved by an alternative subset(s) of reg-opment by augmenting endogenous levels of IL-4 (Fig-
ure 2). ulatory T cells by the production of TGFb, which is able
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